Best GHK-Cu Providers in 2026 — Ranked & Reviewed
GHK-Cu is a copper-binding peptide prescribed for skin, hair, and tissue repair, available compounded as an injection or a topical. As with every peptide in this category, the meaningful difference between sellers is whether a licensed clinician is involved at all. The providers below all prescribe through one, and each is independently scored.
26 providers compared
New to GHK-Cu? Read our full GHK-Cu guide — evidence, dosing, safety and side effects.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
26 ghk-cu providers compared · independently scored against our six-factor methodology.
Compare the top providers at a glance
Logos, our editorial rating, price, medications, and coverage — the fastest way to narrow the list.
- ★ Editor's Pick
mainstream telehealth GLP-1 access
From /moCheck pricingCoverageCheck intakeMedicationsGHK-CuGlutathioneNAD+Sermorelin - Nationwide Coverage
Science-forward GLP-1 and peptide care nationwide, with flat-rate dosing and built-in clinical follow-up
From /moCheck pricingCoverage50 statesMedicationsBPC-157CJC-1295 / IpamorelinGHK-CuGlutathioneIpamorelinNAD+PT-141SermorelinTB-500Tesamorelin Women in menopause wanting GLP-1 weight care alongside HRT, from board-certified physicians
From /moCheck pricingCoverageCheck intakeMedicationsGHK-Cu- Best Budget
compounded GLP-1s from $83/mo all-in with brand Wegovy and Zepbound upgrade paths
From /moCheck pricingCoverage36 statesMedicationsGHK-CuGlutathioneNAD+Sermorelin shoppers who want low-cost, physician-led compounded GLP-1 with peptide and hormone options
From /moCheck pricingCoverage50 statesMedicationsBPC-157CJC-1295 / IpamorelinGHK-CuGlutathioneIpamorelinNAD+TB-500TesamorelinGLP-1 alongside men's and women's hormone-health programs
From /moCheck pricingCoverageCheck intakeMedicationsGHK-CuGlutathioneNAD+Sermorelin- Transparent Pricing
lab-required GLP-1 care with named pharmacy partners
From /moCheck pricingCoverageCheck intakeMedicationsGHK-CuGlutathioneNAD+Sermorelin Patients wanting sublingual ODT GLP-1 tablets or a needle-free weight-loss option
From /moCheck pricingCoverage50 statesMedicationsCJC-1295 / IpamorelinGHK-CuGlutathioneNAD+SermorelinTesamorelin
| Provider | Rating | From /mo | Medications | Coverage | |
|---|---|---|---|---|---|
★ Editor's Pick mainstream telehealth GLP-1 access | Check pricing | GHK-CuGlutathioneNAD+Sermorelin | Check intake | Visit → | |
Nationwide Coverage Science-forward GLP-1 and peptide care nationwide, with flat-rate dosing and built-in clinical follow-up | Check pricing | BPC-157CJC-1295 / IpamorelinGHK-CuGlutathioneIpamorelinNAD+PT-141SermorelinTB-500Tesamorelin | 50 states | Visit → | |
 Women in menopause wanting GLP-1 weight care alongside HRT, from board-certified physicians | Check pricing | GHK-Cu | Check intake | Visit → | |
Best Budget compounded GLP-1s from $83/mo all-in with brand Wegovy and Zepbound upgrade paths | Check pricing | GHK-CuGlutathioneNAD+Sermorelin | 36 states | Visit → | |
 shoppers who want low-cost, physician-led compounded GLP-1 with peptide and hormone options | Check pricing | BPC-157CJC-1295 / IpamorelinGHK-CuGlutathioneIpamorelinNAD+TB-500Tesamorelin | 50 states | Visit → | |
 GLP-1 alongside men's and women's hormone-health programs | Check pricing | GHK-CuGlutathioneNAD+Sermorelin | Check intake | Visit → | |
Transparent Pricing lab-required GLP-1 care with named pharmacy partners | Check pricing | GHK-CuGlutathioneNAD+Sermorelin | Check intake | Visit → | |
 Patients wanting sublingual ODT GLP-1 tablets or a needle-free weight-loss option | Check pricing | CJC-1295 / IpamorelinGHK-CuGlutathioneNAD+SermorelinTesamorelin | 50 states | Visit → |
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
Detailed Reviews
A note on prices below: any dollar figure in these provider summaries refers to that clinic’s GLP‑1 weight-loss program, not to GHK-Cu. Peptide pricing is rarely published up front — check the provider’s own site for current cost.
ShedRx
Verified partnerBest for: mainstream telehealth GLP-1 access
Telehealth provider offering compounded GLP-1 medications in injectable, lozenge, and drop formats.
Score Breakdown
Pros
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
- ✓Multiple administration formats
Cons
- ✗Limited public information on program details
YourHealthRx
Best for: Science-forward GLP-1 and peptide care nationwide, with flat-rate dosing and built-in clinical follow-up
YourHealthRx is a scientist-founded peptide and GLP-1 telehealth platform available in all 50 states and DC via a multi-state (IMLC) clinician network. Compounded semaglutide and tirzepatide come as a weekly injectable (with B12) or a daily oral tablet, at a flat subscription price that doesn't change with your dose - injectable semaglutide ~$170/mo and tirzepatide ~$210/mo ongoing. It also offers a broad peptide catalog plus lab testing. Prescribing runs through partner clinical workflows; compounded meds aren't FDA-approved, the pharmacy isn't named, and no LegitScript is shown.
Score Breakdown
Pros
- ✓Available in all 50 states and DC through a multi-state (IMLC) licensed clinician network
- ✓Compounded semaglutide and tirzepatide in two formats - weekly injectable (with B12) or daily oral dissolving tablet
- ✓Flat subscription price that doesn't change as your dose increases (no titration penalty)
- ✓Science-forward, clinician-led, with built-in follow-up, lab testing, and a broad peptide and longevity catalog (BPC-157, TB-500, sermorelin, NAD+)
- ✓Transparent, education-first positioning with published medical disclaimer, privacy, and terms
Cons
- ✗Eligibility and prescribing run through partner clinical workflows - YourHealthRx is the platform, not the prescriber or pharmacy
- ✗Compounded medications are not FDA-approved - not brand Wegovy, Ozempic, Zepbound, or Mounjaro
- ✗The compounding pharmacy partner is not named ('transparent sourcing' claimed but no pharmacy disclosed)
- ✗Headline prices include a first-month intro rate; ongoing monthly cost is higher (semaglutide ~$170, tirzepatide ~$210)
- ✗No LegitScript certification displayed
Kina
Best for: Women in menopause wanting GLP-1 weight care alongside HRT, from board-certified physicians
Kina is a menopause-care telehealth platform where GLP-1 is the weight-loss treatment, offered alongside HRT, peptide, and compounded options for menopause symptoms. Its GLP-1 program provides compounded semaglutide and tirzepatide from $179/month (plus a $50 physician consult; $0 membership), prescribed and monitored by board-certified physicians at Arora Health & Aesthetics. It carries verifiable LegitScript certification, is FSA/HSA eligible, ships free, and is cancel-anytime. Compounded medications are not FDA-approved; the pharmacy is not named.
Score Breakdown
Pros
- ✓Menopause-specialized care — GLP-1 weight treatment alongside HRT, peptide, and compounded options for menopause symptoms
- ✓Prescribed and monitored by named board-certified physicians at Arora Health & Aesthetics, with dose adjustments included
- ✓Verifiable LegitScript certification (seal ID 50917967)
- ✓GLP-1 from $179/month with $0 membership fees, FSA/HSA eligibility, free shipping, and cancel-anytime
- ✓Compounded semaglutide and tirzepatide, 100% online with a roughly 2-minute intake
Cons
- ✗Compounded medications are not FDA-approved — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
- ✗Built for women navigating menopause — less tailored if that is not your situation
- ✗A separate $50 physician consultation fee applies on top of the medication price
- ✗The compounding pharmacy partner is not named, and the full list of served states is not published
PreventiveMD
Best for: compounded GLP-1s from $83/mo all-in with brand Wegovy and Zepbound upgrade paths
PreventiveMD is a physician-guided telehealth platform for GLP-1 weight loss and peptide therapy, offering compounded semaglutide from $83/mo all-in and compounded tirzepatide from $97/mo all-in, plus brand Wegovy, Zepbound, and Foundayo on a membership model. A US-licensed provider reviews each request within 24 hours; approved medication ships to your door with ongoing care through an online portal.
Score Breakdown
Pros
- ✓Compounded semaglutide from $83/mo and tirzepatide from $97/mo, billed as one all-in monthly price
- ✓Brand Wegovy, Zepbound, and Foundayo (oral GLP-1) available on the same platform
- ✓US-licensed provider reviews requests within 24 hours — no video visit required
- ✓You aren't charged until a provider approves; checkout places an authorization hold only
- ✓LegitScript-certified; works exclusively with state-licensed US 503A compounding pharmacies
- ✓HSA/FSA-eligible with receipts you can submit to your insurer
- ✓Publishes its state-availability list openly on the site
Cons
- ✗Individual compounding pharmacy partners are not publicly named
- ✗Not available in 14 states + DC, including New York, New Jersey, Virginia, and Wisconsin
- ✗Brand Wegovy, Zepbound, and Foundayo require a $49/mo membership fee on top of medication cost
- ✗'As low as' pricing — actual monthly cost can be higher depending on your plan
- ✗Orders become non-refundable once provider review or pharmacy fulfillment begins
Live Vital
Verified partnerBest for: shoppers who want low-cost, physician-led compounded GLP-1 with peptide and hormone options
Live Vital is a physician-led telehealth practice founded by Dr. Patrick Taylor, MD, offering compounded GLP-1 weight loss — semaglutide from $99/mo and tirzepatide from $183/mo, billed as 3-month programs — alongside peptide and hormone therapy. Every plan is doctor-prescribed, filled by a licensed US pharmacy, and shipped to your door, with unlimited care-team messaging and no lock-in. Fully telehealth in all 50 states.
Score Breakdown
Pros
- ✓Physician-led — founded by Dr. Patrick Taylor, MD; all treatments doctor-prescribed via the clinical team
- ✓Transparent published pricing: semaglutide from $99/mo, tirzepatide from $183/mo (billed as 3-month programs)
- ✓Every plan includes doctor prescribing, licensed-pharmacy medication, and direct-to-door shipping
- ✓Unlimited messaging with the care team; cancel or pause anytime with no lock-in
- ✓Fully telehealth in all 50 states
Cons
- ✗Sold as 3-month programs (semaglutide $299 / tirzepatide $549 per quarter); 'starting at' rates can rise with dose
- ✗Doesn't accept insurance (HSA/FSA funds only)
- ✗Compounding pharmacy isn't named (only 'a licensed US pharmacy')
- ✗Also a peptide/longevity practice; those peptides are not FDA-approved (the site discloses this)
How we rank & what counts as “legit”
Every provider in this ranking is scored against our published six-factor rubric[1] — value, effectiveness, user experience, trust & safety, accessibility, and support.
Brand-name Wegovy, Zepbound, Ozempic, and Mounjaro are separately FDA-approved under their own NDA numbers[4][5]. Published Phase 3 efficacy for semaglutide 2.4 mg (~14.9% mean weight loss over 68 weeks) comes from the STEP 1 trial[6], and for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) from SURMOUNT-1[7]; the SURMOUNT-5 head-to-head published in 2025 compared the two directly[8].
Insurance coverage for anti-obesity medications varies widely by state Medicaid program and commercial plan[9][10]. Compounded and brand-name GLP-1s are generally FSA/HSA eligible with a prescription under IRS Publication 502[11].
Frequently Asked Questions
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
- 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
- 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.